VRT
Vertex Pharmaceuticals-Established Wholesale Acquisition Cost for Alyftrek in United States of $370,269 on Annual Basis ($28,404 per 28-Day Pack)
时间：2024-12-21 05:12:08 市场： 美股 综合
Vertex Announces US FDA Approval of Alyftrek™, a Once-Daily Next-in-Class Cftr Modulator for the Treatment of Cystic Fibrosis
时间：2024-12-21 04:46:00 市场： 美股 综合
Vertex Announces U.S. FDA Approval for Trikafta (Elexacaftor/Tezacaftor/Ivacaftor and Ivacaftor) to Include Additional Non-F508del Trikafta-Responsive Variants
时间：2024-12-21 04:35:00 市场： 美股 综合
Vertiv Acquires Centrifugal Chiller Technology to Broaden Its Global Solutions Portfolio in Support of High-Performance Compute and AI
时间：2024-12-20 19:30:00 市场： 美股 综合
Vertex Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $542 From $600
时间：2024-12-20 19:04:46 市场： 美股 综合
Vertex Pharmaceuticals Shares Down 2.6% Premarket ; Co's Non-Opioid Drug Meets Main Goal in Mid-Stage Nerve Pain Trial
时间：2024-12-19 19:11:26 市场： 美股 综合
Vertiv Holdings Co. : Barclays Initiates Coverage With Equal-Weight Rating and Target Price $142
时间：2024-12-12 14:17:01 市场： 美股 综合
Virtus Investment Partners Announces Appointment of Board Member
时间：2024-12-12 05:05:01 市场： 美股 综合
Vertiv Holdings Co. : Oppenheimer Raises Target Price to $131 From $121
时间：2024-11-19 21:12:19 市场： 美股 综合
Vertiv Holdings Co : Deutsche Bank Raises Target Price to $135 From $133
时间：2024-11-19 20:20:40 市场： 综合 美股